324 related articles for article (PubMed ID: 32694655)
1. Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria.
Zampara A; Sørensen MCH; Grimon D; Antenucci F; Vitt AR; Bortolaia V; Briers Y; Brøndsted L
Sci Rep; 2020 Jul; 10(1):12087. PubMed ID: 32694655
[TBL] [Abstract][Full Text] [Related]
2. Developing Innolysins Against
Zampara A; Sørensen MCH; Gencay YE; Grimon D; Kristiansen SH; Jørgensen LS; Kristensen JR; Briers Y; Elsser-Gravesen A; Brøndsted L
Front Microbiol; 2021; 12():619028. PubMed ID: 33597938
[No Abstract] [Full Text] [Related]
3. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
[TBL] [Abstract][Full Text] [Related]
4. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of SAR-endolysin LysKpV475 with polymyxin B and
Gontijo M; Pereira Teles M; Martins Correia H; Pérez Jorge G; Rodrigues Santos Goes IC; Fasabi Flores AJ; Braz M; de Moraes Ceseti L; Zonzini Ramos P; Rosa E Silva I; Pereira Vidigal PM; Kobarg J; Miguez Couñago R; Alvarez-Martinez CE; Pereira C; Freire CSR; Almeida A; Brocchi M
Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739436
[TBL] [Abstract][Full Text] [Related]
6. Characterization of five novel endolysins from Gram-negative infecting bacteriophages.
Walmagh M; Boczkowska B; Grymonprez B; Briers Y; Drulis-Kawa Z; Lavigne R
Appl Microbiol Biotechnol; 2013 May; 97(10):4369-75. PubMed ID: 22832988
[TBL] [Abstract][Full Text] [Related]
7. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
Briers Y; Lavigne R
Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
[TBL] [Abstract][Full Text] [Related]
8. Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.
Walmagh M; Briers Y; dos Santos SB; Azeredo J; Lavigne R
PLoS One; 2012; 7(5):e36991. PubMed ID: 22615864
[TBL] [Abstract][Full Text] [Related]
9. 'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.
Rodríguez-Rubio L; Chang WL; Gutiérrez D; Lavigne R; Martínez B; Rodríguez A; Govers SK; Aertsen A; Hirl C; Biebl M; Briers Y; García P
Sci Rep; 2016 Oct; 6():35382. PubMed ID: 27775093
[TBL] [Abstract][Full Text] [Related]
10. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
Lim JA; Shin H; Heu S; Ryu S
J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
[TBL] [Abstract][Full Text] [Related]
11. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
Kim S; Jin JS; Choi YJ; Kim J
Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
[TBL] [Abstract][Full Text] [Related]
12. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a high-affinity complex between the bacterial outer membrane protein FhuA and the phage T5 protein pb5.
Plançon L; Janmot C; le Maire M; Desmadril M; Bonhivers M; Letellier L; Boulanger P
J Mol Biol; 2002 Apr; 318(2):557-69. PubMed ID: 12051859
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage endolysins as a novel class of antibacterial agents.
Borysowski J; Weber-Dabrowska B; Górski A
Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
[TBL] [Abstract][Full Text] [Related]
15. The influence of cationic dendrimers on antibacterial activity of phage endolysin against P. aeruginosa cells.
Ciepluch K; Maciejewska B; Gałczyńska K; Kuc-Ciepluch D; Bryszewska M; Appelhans D; Drulis-Kawa Z; Arabski M
Bioorg Chem; 2019 Oct; 91():103121. PubMed ID: 31310881
[TBL] [Abstract][Full Text] [Related]
16. Unveiling the mechanism of bactericidal activity of a cecropin A-fused endolysin LNT113.
Cho J; Hong HW; Park K; Myung H; Yoon H
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129493. PubMed ID: 38224804
[TBL] [Abstract][Full Text] [Related]
17. New insights into pb5, the receptor binding protein of bacteriophage T5, and its interaction with its Escherichia coli receptor FhuA.
Flayhan A; Wien F; Paternostre M; Boulanger P; Breyton C
Biochimie; 2012 Sep; 94(9):1982-9. PubMed ID: 22659573
[TBL] [Abstract][Full Text] [Related]
18. Lysis of cells of diverse bacteria by l,d-peptidases of Escherichia coli bacteriophages RB43, RB49 and T5.
Shadrin VS; Machulin AV; Dorofeeva LV; Chernyshov SV; Mikoulinskaia GV
J Appl Microbiol; 2021 Jun; 130(6):1902-1912. PubMed ID: 33107183
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Three Different Endolysins Effective against Gram-Negative Bacteria.
Jeong TH; Hong HW; Kim MS; Song M; Myung H
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992387
[TBL] [Abstract][Full Text] [Related]
20. Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin.
Park W; Park M; Chun J; Hwang J; Kim S; Choi N; Kim SM; Kim S; Jung S; Ko KS; Kweon DH
Int J Antimicrob Agents; 2024 May; 64(2):107216. PubMed ID: 38795926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
